Anna M. Schotthoefer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anna M. Schotthoefer has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
- Alison F. Hinckley
Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, USA
3 shared publications - Brian S. Schwartz
Department of Population Health Sciences, Geisinger, Danville, PA
3 shared publications - Alexandra M. Linz
Department of Bacteriology, University of Wisconsin-Madison, Madison, Wisconsin, USA
2 shared publications - Annemarie Gregory Hirsch
Department of Population Health Sciences, Geisinger, Danville, PA, United States
2 shared publications - Cara M. Nordberg
Department of Population Health Sciences, Geisinger, 100 North Academy Avenue, Danville, PA, 17822, USA
2 shared publications - Cassandra A. Hathaway
Westat , Rockville, Maryland
2 shared publications
Latest Publications
- Open Access
- 8 July 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e94921
Using Electronic Health Records to Enhance Lyme Disease Surveillance: Protocol for the SubLyme Network
Background: Lyme disease is the most common vector-borne illness in the United States. The limitations of traditional surveillance strategies for Lyme disease affect the ability to reliably track its burden and evaluate interventions. The US Centers for Disease Control and Prevention (CDC) established the Surveillance Based Lyme Disease Network (SubLyme) in September 2023 to strengthen Lyme disease surveillance and research using electronic health record (EHR) data. Objective: SubLyme has three primary objectives: (1) to establish and evaluate criteria for identifying Lyme disease cases in EHR data (ie, create computable phenotypes [CPs]) that can be scaled across diverse health systems, (2) to estimate Lyme disease incidence, and (3) to describe Lyme disease incidence by key demographics. Secondary objectives are to develop CPs that distinguish between acute and disseminated Lyme disease, identify clinical manifestations, and support future research efforts. This paper describes SubLyme, its structure, and its methods. Methods: SubLyme includes 5 health systems in 3 US regions with a high risk of Lyme disease: Geisinger, in Pennsylvania; Marshfield Clinic Health System, in Wisconsin; and Mass General Brigham, Tufts Medical Center, and MaineHealth in New England. The network is administered by a coordinating center (Westat) and the US CDC. SubLyme is evaluating the validity of EHR-based CP definitions for Lyme disease. CP performance is assessed by measuring sensitivity, specificity, positive predictive value, and negative predictive value against manually abstracted medical charts. Each site identified a cohort of patients with any Lyme disease element in their EHR (Lyme disease diagnosis code, Lyme disease laboratory test order, and Lyme-appropriate antibiotic order) during 2022 to 2023 and selected 500 charts for manual review as the gold standard against which CP performance was evaluated. SubLyme will use the Lyme disease CPs to generate incidence rates for Lyme disease overall and for various subgroups. Results: SubLyme identified 332,256 patients with at least 1 Lyme disease element in their record from more than 4.6 million patients. Of these patients, 55.6% (n=184,734) were female, 87.9% (n=292,053) were White, and 90.8% (n=301,688) were non-Hispanic. More than half of the patients only had a Lyme-appropriate medication order (n=177,425, 53.4%) and 35.8% (n=118,948) only had a Lyme disease test order. The most common combination was a medication order with a laboratory test order (n=22,926, 6.9%), followed by a combination of a diagnosis, test, and medication order (n=5316, 1.6%). Conclusions: SubLyme is well positioned to advance Lyme disease surveillance using EHR data across multiple health systems. The exploration of new surveillance methods in Lyme disease is critical as disease frequency increases and the geography expands. An EHR-based approach to surveillance has the potential to overcome challenges of current surveillance strategies and to accelerate Lyme disease research. International Registered Report Identifier (IRRID): DERR1-10.2196/94921
- 8 July 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e94921
Open AccessUsing Electronic Health Records to Enhance Lyme Disease Surveillance: Protocol for the SubLyme Network
Background: Lyme disease is the most common vector-borne illness in the United States. The limitations of traditional surveillance strategies for Lyme disease affect the ability to reliably track its burden and evaluate interventions. The US Centers for Disease Control and Prevention (CDC) established the Surveillance Based Lyme Disease Network (SubLyme) in September 2023 to strengthen Lyme disease surveillance and research using electronic health record (EHR) data. Objective: SubLyme has three primary objectives: (1) to establish and evaluate criteria for identifying Lyme disease cases in EHR data (ie, create computable phenotypes [CPs]) that can be scaled across diverse health systems, (2) to estimate Lyme disease incidence, and (3) to describe Lyme disease incidence by key demographics. Secondary objectives are to develop CPs that distinguish between acute and disseminated Lyme disease, identify clinical manifestations, and support future research efforts. This paper describes SubLyme, its structure, and its methods. Methods: SubLyme includes 5 health systems in 3 US regions with a high risk of Lyme disease: Geisinger, in Pennsylvania; Marshfield Clinic Health System, in Wisconsin; and Mass General Brigham, Tufts Medical Center, and MaineHealth in New England. The network is administered by a coordinating center (Westat) and the US CDC. SubLyme is evaluating the validity of EHR-based CP definitions for Lyme disease. CP performance is assessed by measuring sensitivity, specificity, positive predictive value, and negative predictive value against manually abstracted medical charts. Each site identified a cohort of patients with any Lyme disease element in their EHR (Lyme disease diagnosis code, Lyme disease laboratory test order, and Lyme-appropriate antibiotic order) during 2022 to 2023 and selected 500 charts for manual review as the gold standard against which CP performance was evaluated. SubLyme will use the Lyme disease CPs to generate incidence rates for Lyme disease overall and for various subgroups. Results: SubLyme identified 332,256 patients with at least 1 Lyme disease element in their record from more than 4.6 million patients. Of these patients, 55.6% (n=184,734) were female, 87.9% (n=292,053) were White, and 90.8% (n=301,688) were non-Hispanic. More than half of the patients only had a Lyme-appropriate medication order (n=177,425, 53.4%) and 35.8% (n=118,948) only had a Lyme disease test order. The most common combination was a medication order with a laboratory test order (n=22,926, 6.9%), followed by a combination of a diagnosis, test, and medication order (n=5316, 1.6%). Conclusions: SubLyme is well positioned to advance Lyme disease surveillance using EHR data across multiple health systems. The exploration of new surveillance methods in Lyme disease is critical as disease frequency increases and the geography expands. An EHR-based approach to surveillance has the potential to overcome challenges of current surveillance strategies and to accelerate Lyme disease research. International Registered Report Identifier (IRRID): DERR1-10.2196/94921
- Open Access
- 13 May 2026
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 64 (5) , e0118725
Evaluation of standard and modified two-tiered testing algorithms using well-characterized early Lyme disease samples
Current laboratory testing for Lyme disease (LD) relies on serology. We evaluated the performance of standard two-tiered testing (STTT) and modified two-tiered testing (MTTT) algorithms using samples obtained from well-characterized patients with early LD in the U.S. East Coast and Upper Midwest. Participants with signs and symptoms of early LD (cases) and controls were enrolled by Lyme Disease Biobank. We compared the performance of four FDA-cleared STTT or MTTT algorithms using serum samples from 251 participants (107 cases, 69 with a convalescent draw; 144 endemic controls). At the initial blood draw, algorithm sensitivity ranged from 22% to 36%, with specificity ranging from 98% to 100%. MTTT algorithms showed higher sensitivity compared with STTT algorithms ( P ≤ 0.05). One STTT algorithm was less sensitive than the other ( P = 0.035), and there was no significant difference in sensitivity between MTTT algorithms. There was also discordance between algorithms; only 22 of the 45 samples classified as laboratory confirmed by Lyme Disease Biobank testing were positive using all algorithms evaluated. Likelihood of positive two-tiered serology among cases with a suspected erythema migrans (EM) skin lesion increased with longer lesion duration and/or when presenting with >1 constitutional symptom. Participants with suspected EM without constitutional symptoms were unlikely to test positive by any algorithm evaluated. Testing convalescent samples did not improve LD detection, and seroconversion was rare. While MTTT confirmed more early LD cases than STTT, all two-tiered algorithms evaluated were insensitive in this population. Novel diagnostics that improve laboratory confirmation for early LD are urgently needed. IMPORTANCE: This study confirms that two-tiered serologic testing algorithms are insensitive in early Lyme disease, particularly within the first 2 weeks after symptom onset or when erythema migrans is not accompanied by constitutional symptoms. It also demonstrates that seroconversion is rare after antibiotic treatment. These results highlight the need for novel diagnostics for early Lyme disease that do not rely on serologic testing.
- 13 May 2026
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 64 (5) , e0118725
Open AccessEvaluation of standard and modified two-tiered testing algorithms using well-characterized early Lyme disease samples
Current laboratory testing for Lyme disease (LD) relies on serology. We evaluated the performance of standard two-tiered testing (STTT) and modified two-tiered testing (MTTT) algorithms using samples obtained from well-characterized patients with early LD in the U.S. East Coast and Upper Midwest. Participants with signs and symptoms of early LD (cases) and controls were enrolled by Lyme Disease Biobank. We compared the performance of four FDA-cleared STTT or MTTT algorithms using serum samples from 251 participants (107 cases, 69 with a convalescent draw; 144 endemic controls). At the initial blood draw, algorithm sensitivity ranged from 22% to 36%, with specificity ranging from 98% to 100%. MTTT algorithms showed higher sensitivity compared with STTT algorithms ( P ≤ 0.05). One STTT algorithm was less sensitive than the other ( P = 0.035), and there was no significant difference in sensitivity between MTTT algorithms. There was also discordance between algorithms; only 22 of the 45 samples classified as laboratory confirmed by Lyme Disease Biobank testing were positive using all algorithms evaluated. Likelihood of positive two-tiered serology among cases with a suspected erythema migrans (EM) skin lesion increased with longer lesion duration and/or when presenting with >1 constitutional symptom. Participants with suspected EM without constitutional symptoms were unlikely to test positive by any algorithm evaluated. Testing convalescent samples did not improve LD detection, and seroconversion was rare. While MTTT confirmed more early LD cases than STTT, all two-tiered algorithms evaluated were insensitive in this population. Novel diagnostics that improve laboratory confirmation for early LD are urgently needed. IMPORTANCE: This study confirms that two-tiered serologic testing algorithms are insensitive in early Lyme disease, particularly within the first 2 weeks after symptom onset or when erythema migrans is not accompanied by constitutional symptoms. It also demonstrates that seroconversion is rare after antibiotic treatment. These results highlight the need for novel diagnostics for early Lyme disease that do not rely on serologic testing.
- Open Access
- 8 March 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Using Electronic Health Records to Enhance Lyme Disease Surveillance: Protocol for the SubLyme Network (Preprint)
BACKGROUND Lyme disease is the most common vector-borne illness in the United States. The limitations of traditional surveillance strategies for Lyme disease affect the ability to reliably track its burden and evaluate interventions. The US Centers for Disease Control and Prevention (CDC) established the Surveillance Based Lyme Disease Network (SubLyme) in September 2023 to strengthen Lyme disease surveillance and research using electronic health record (EHR) data. OBJECTIVE SubLyme has three primary objectives: (1) to establish and evaluate criteria for identifying Lyme disease cases in EHR data (ie, create computable phenotypes [CPs]) that can be scaled across diverse health systems, (2) to estimate Lyme disease incidence, and (3) to describe Lyme disease incidence by key demographics. Secondary objectives are to develop CPs that distinguish between acute and disseminated Lyme disease, identify clinical manifestations, and support future research efforts. This paper describes SubLyme, its structure, and its methods. METHODS SubLyme includes 5 health systems in 3 US regions with a high risk of Lyme disease: Geisinger, in Pennsylvania; Marshfield Clinic Health System, in Wisconsin; and Mass General Brigham, Tufts Medical Center, and MaineHealth in New England. The network is administered by a coordinating center (Westat) and the US CDC. SubLyme is evaluating the validity of EHR-based CP definitions for Lyme disease. CP performance is assessed by measuring sensitivity, specificity, positive predictive value, and negative predictive value against manually abstracted medical charts. Each site identified a cohort of patients with any Lyme disease element in their EHR (Lyme disease diagnosis code, Lyme disease laboratory test order, and Lyme-appropriate antibiotic order) during 2022 to 2023 and selected 500 charts for manual review as the gold standard against which CP performance was evaluated. SubLyme will use the Lyme disease CPs to generate incidence rates for Lyme disease overall and for various subgroups. RESULTS SubLyme identified 332,256 patients with at least 1 Lyme disease element in their record from more than 4.6 million patients. Of these patients, 55.6% (n=184,734) were female, 87.9% (n=292,053) were White, and 90.8% (n=301,688) were non-Hispanic. More than half of the patients only had a Lyme-appropriate medication order (n=177,425, 53.4%) and 35.8% (n=118,948) only had a Lyme disease test order. The most common combination was a medication order with a laboratory test order (n=22,926, 6.9%), followed by a combination of a diagnosis, test, and medication order (n=5316, 1.6%). CONCLUSIONS SubLyme is well positioned to advance Lyme disease surveillance using EHR data across multiple health systems. The exploration of new surveillance methods in Lyme disease is critical as disease frequency increases and the geography expands. An EHR-based approach to surveillance has the potential to overcome challenges of current surveillance strategies and to accelerate Lyme disease research. INTERNATIONAL REGISTERED REPORT DERR1-10.2196/94921
- 8 March 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessUsing Electronic Health Records to Enhance Lyme Disease Surveillance: Protocol for the SubLyme Network (Preprint)
BACKGROUND Lyme disease is the most common vector-borne illness in the United States. The limitations of traditional surveillance strategies for Lyme disease affect the ability to reliably track its burden and evaluate interventions. The US Centers for Disease Control and Prevention (CDC) established the Surveillance Based Lyme Disease Network (SubLyme) in September 2023 to strengthen Lyme disease surveillance and research using electronic health record (EHR) data. OBJECTIVE SubLyme has three primary objectives: (1) to establish and evaluate criteria for identifying Lyme disease cases in EHR data (ie, create computable phenotypes [CPs]) that can be scaled across diverse health systems, (2) to estimate Lyme disease incidence, and (3) to describe Lyme disease incidence by key demographics. Secondary objectives are to develop CPs that distinguish between acute and disseminated Lyme disease, identify clinical manifestations, and support future research efforts. This paper describes SubLyme, its structure, and its methods. METHODS SubLyme includes 5 health systems in 3 US regions with a high risk of Lyme disease: Geisinger, in Pennsylvania; Marshfield Clinic Health System, in Wisconsin; and Mass General Brigham, Tufts Medical Center, and MaineHealth in New England. The network is administered by a coordinating center (Westat) and the US CDC. SubLyme is evaluating the validity of EHR-based CP definitions for Lyme disease. CP performance is assessed by measuring sensitivity, specificity, positive predictive value, and negative predictive value against manually abstracted medical charts. Each site identified a cohort of patients with any Lyme disease element in their EHR (Lyme disease diagnosis code, Lyme disease laboratory test order, and Lyme-appropriate antibiotic order) during 2022 to 2023 and selected 500 charts for manual review as the gold standard against which CP performance was evaluated. SubLyme will use the Lyme disease CPs to generate incidence rates for Lyme disease overall and for various subgroups. RESULTS SubLyme identified 332,256 patients with at least 1 Lyme disease element in their record from more than 4.6 million patients. Of these patients, 55.6% (n=184,734) were female, 87.9% (n=292,053) were White, and 90.8% (n=301,688) were non-Hispanic. More than half of the patients only had a Lyme-appropriate medication order (n=177,425, 53.4%) and 35.8% (n=118,948) only had a Lyme disease test order. The most common combination was a medication order with a laboratory test order (n=22,926, 6.9%), followed by a combination of a diagnosis, test, and medication order (n=5316, 1.6%). CONCLUSIONS SubLyme is well positioned to advance Lyme disease surveillance using EHR data across multiple health systems. The exploration of new surveillance methods in Lyme disease is critical as disease frequency increases and the geography expands. An EHR-based approach to surveillance has the potential to overcome challenges of current surveillance strategies and to accelerate Lyme disease research. INTERNATIONAL REGISTERED REPORT DERR1-10.2196/94921
- Open Access
- 14 February 2026
- Published by MDPI AG in Infectious Disease Reports
- Vol. 18 (1) , 19
Post-Exposure Prophylaxis Prescribing Practices in a Lyme Disease-Endemic Area
Background/Objectives: The 2020 Infectious Diseases Society of America (IDSA) guidelines recommend a single 200 mg dose of doxycycline within 72 h of tick removal after a high-risk bite for Lyme disease prophylaxis. However, limited data are available on prescribing practices related to this recommendation in highly endemic Lyme disease areas. Methods: We conducted a retrospective chart review on adult patients (aged ≥ 18 years) who received a single dose of oral doxycycline for Lyme disease prevention for the period 2022–2024 within a rural Wisconsin health system. Patient and provider prescribing characteristics were evaluated. Manual data abstraction was performed on a random sample of 155 prescribing events to assess adherence to IDSA guidelines. Results: A total of 2404 prophylaxis prescriptions were identified; 44% were prescribed to older adults between 65 and 79 years of age, 54% were prescribed to males, and 66% were prescribed to patients living in rural areas. Prescriptions peaked in spring and summer months, consistent with the known seasonal trends in tick activity. Prescribing was distributed relatively evenly across provider types, with the majority (77%) of cases occurring in outpatient and urgent care settings. Upon manual abstraction, doxycycline was indicated in 12% with the remainder either classified as possibly indicated or not indicated due to suboptimal documentation and nonadherence. Conclusions: Our study identified high rates of incomplete documentation and uncertainty in guideline concordance in a Lyme-endemic health system, highlighting the opportunities to support evidence-based prescribing and to improve documentation practices.
- 14 February 2026
- Published by MDPI AG in Infectious Disease Reports
- Vol. 18 (1) , 19
Open AccessPost-Exposure Prophylaxis Prescribing Practices in a Lyme Disease-Endemic Area
Background/Objectives: The 2020 Infectious Diseases Society of America (IDSA) guidelines recommend a single 200 mg dose of doxycycline within 72 h of tick removal after a high-risk bite for Lyme disease prophylaxis. However, limited data are available on prescribing practices related to this recommendation in highly endemic Lyme disease areas. Methods: We conducted a retrospective chart review on adult patients (aged ≥ 18 years) who received a single dose of oral doxycycline for Lyme disease prevention for the period 2022–2024 within a rural Wisconsin health system. Patient and provider prescribing characteristics were evaluated. Manual data abstraction was performed on a random sample of 155 prescribing events to assess adherence to IDSA guidelines. Results: A total of 2404 prophylaxis prescriptions were identified; 44% were prescribed to older adults between 65 and 79 years of age, 54% were prescribed to males, and 66% were prescribed to patients living in rural areas. Prescriptions peaked in spring and summer months, consistent with the known seasonal trends in tick activity. Prescribing was distributed relatively evenly across provider types, with the majority (77%) of cases occurring in outpatient and urgent care settings. Upon manual abstraction, doxycycline was indicated in 12% with the remainder either classified as possibly indicated or not indicated due to suboptimal documentation and nonadherence. Conclusions: Our study identified high rates of incomplete documentation and uncertainty in guideline concordance in a Lyme-endemic health system, highlighting the opportunities to support evidence-based prescribing and to improve documentation practices.
- Open Access
- 12 November 2025
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 63 (11) , e0102025
The potential to improve Lyme disease diagnostics through quantification of immunoglobulin class switching patterns
N. Nair, A. Marques , E. J. Horn, G. Brown et al., J Clin Microbiol 63:e0034725, 2025, https://doi.org/10.1128/jcm.00347-25 present data to demonstrate that infection by Borrelia burgdorferi , the primary causative agent of Lyme disease in the USA, leads to immunoglobulin class switching in antibodies specifically against the immunodominant antigen, VlsE (variable major protein-like sequence, expressed), in a predictable pattern between the early acute (B . burgdorferi antibody response. Applying multivariate and machine learning modeling methods, they found the profile of isotypes quantified performed particularly well at correctly classifying early acute sera samples. They also identified IgG4 as a potential biomarker unique to Lyme arthritis patients. Overall, the findings suggest that improvements in Lyme disease diagnostics may be attained by quantifying specific antibody isotypes against B. burgdorferi antigens.
- 12 November 2025
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 63 (11) , e0102025
Open AccessThe potential to improve Lyme disease diagnostics through quantification of immunoglobulin class switching patterns
N. Nair, A. Marques , E. J. Horn, G. Brown et al., J Clin Microbiol 63:e0034725, 2025, https://doi.org/10.1128/jcm.00347-25 present data to demonstrate that infection by Borrelia burgdorferi , the primary causative agent of Lyme disease in the USA, leads to immunoglobulin class switching in antibodies specifically against the immunodominant antigen, VlsE (variable major protein-like sequence, expressed), in a predictable pattern between the early acute (B . burgdorferi antibody response. Applying multivariate and machine learning modeling methods, they found the profile of isotypes quantified performed particularly well at correctly classifying early acute sera samples. They also identified IgG4 as a potential biomarker unique to Lyme arthritis patients. Overall, the findings suggest that improvements in Lyme disease diagnostics may be attained by quantifying specific antibody isotypes against B. burgdorferi antigens.
- Open Access
- 25 October 2022
- Published by Springer Nature in Cureus
- Vol. 14 (10) , e30673
The Spectrum of Erythema Migrans in Early Lyme Disease: Can We Improve Its Recognition?
Diagnosis of early Lyme disease (LD) often relies on clinical recognition of the skin lesion, erythema migrans (EM), a diagnostic sign of disease when laboratory testing is insensitive. Because EM can present in morphologically distinct forms, its recognition by clinicians can be challenging. This study aimed to characterize the clinical spectrum of lesions in patients presenting with suspected early LD in an ambulatory care setting to identify features that might help clinicians to be better prepared to recognize EM lesions. Images of lesions from 69 participants suspected to have early LD were retrospectively evaluated by a dermatologist and a family practitioner with expertise in early LD. Reviewers made determinations on the diagnoses and morphological features of lesions. Agreement between reviewers and associations among lesion types and participant demographics, symptomology, and laboratory evidence of infection were examined using the kappa statistic and contingency tables, respectively. Challenges in diagnosing EM were evident in our study: initial concordance between reviewers was moderate [kappa statistic (95% CI): 0.45 (0.245 - 0.657)]. The final classification included 35 lesions (51%) that were agreed to be EM; 23 lesions (30%) were considered to be possible early EM or tick bite reactions, and 11 (16%) were thought not to be EM, but rather other diagnoses, including ringworm, allergic contact dermatitis, and mosquito bites. Only two lesions (6%) were observed with a classic bull’s eye or ring-within-a-ring pattern. Most EM lesions were uniform (51%), pink (74%), oval lesions (63%), with well-demarcated borders (92%). Early EM or tick bite reactions were typically <5 cm in size (74%), red (52%), round lesions (61%), with a punctum present (100%). Lesions thought not to be EM also tended to be pink or red (64%), round (55%), or uniform (45%) lesions, but also had raised (25%) or irregular borders (33%), which were not commonly observed in the reviewer-classified EM or tick bite reaction lesions. Participants with lesions classified as EM reported that they had the lesions for more days (p = 0.043) and reported more symptoms (p = 0.017) than participants with other lesions. Only 14 (20%) participants overall had positive laboratory evidence for LD; these included 13 (37%) of the participants with EM-classified lesions. EM commonly occurs in forms that are not the classic bull’s eye. Patients often present with lesions that may represent the very early stage of EM or tick bite reactions, and most patients will test negative on currently available laboratory tests, challenging clinicians in making an LD diagnosis or treatment decisions. Additional studies to further characterize the morphological features of EM and how variation in skin lesions may be perceived among clinicians would be helpful for developing guidelines on improving clinician recognition of EM.
- 25 October 2022
- Published by Springer Nature in Cureus
- Vol. 14 (10) , e30673
Open AccessThe Spectrum of Erythema Migrans in Early Lyme Disease: Can We Improve Its Recognition?
Diagnosis of early Lyme disease (LD) often relies on clinical recognition of the skin lesion, erythema migrans (EM), a diagnostic sign of disease when laboratory testing is insensitive. Because EM can present in morphologically distinct forms, its recognition by clinicians can be challenging. This study aimed to characterize the clinical spectrum of lesions in patients presenting with suspected early LD in an ambulatory care setting to identify features that might help clinicians to be better prepared to recognize EM lesions. Images of lesions from 69 participants suspected to have early LD were retrospectively evaluated by a dermatologist and a family practitioner with expertise in early LD. Reviewers made determinations on the diagnoses and morphological features of lesions. Agreement between reviewers and associations among lesion types and participant demographics, symptomology, and laboratory evidence of infection were examined using the kappa statistic and contingency tables, respectively. Challenges in diagnosing EM were evident in our study: initial concordance between reviewers was moderate [kappa statistic (95% CI): 0.45 (0.245 - 0.657)]. The final classification included 35 lesions (51%) that were agreed to be EM; 23 lesions (30%) were considered to be possible early EM or tick bite reactions, and 11 (16%) were thought not to be EM, but rather other diagnoses, including ringworm, allergic contact dermatitis, and mosquito bites. Only two lesions (6%) were observed with a classic bull’s eye or ring-within-a-ring pattern. Most EM lesions were uniform (51%), pink (74%), oval lesions (63%), with well-demarcated borders (92%). Early EM or tick bite reactions were typically <5 cm in size (74%), red (52%), round lesions (61%), with a punctum present (100%). Lesions thought not to be EM also tended to be pink or red (64%), round (55%), or uniform (45%) lesions, but also had raised (25%) or irregular borders (33%), which were not commonly observed in the reviewer-classified EM or tick bite reaction lesions. Participants with lesions classified as EM reported that they had the lesions for more days (p = 0.043) and reported more symptoms (p = 0.017) than participants with other lesions. Only 14 (20%) participants overall had positive laboratory evidence for LD; these included 13 (37%) of the participants with EM-classified lesions. EM commonly occurs in forms that are not the classic bull’s eye. Patients often present with lesions that may represent the very early stage of EM or tick bite reactions, and most patients will test negative on currently available laboratory tests, challenging clinicians in making an LD diagnosis or treatment decisions. Additional studies to further characterize the morphological features of EM and how variation in skin lesions may be perceived among clinicians would be helpful for developing guidelines on improving clinician recognition of EM.
- Open Access
- 4 December 2021
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 8 (Supplement) , S690
1198. Lyme Disease Post-Exposure Prophylaxis by Single-Dose Doxycycline in Three Healthcare Systems
Lyme disease, the most common tickborne disease in the United States, may be prevented by taking a single 200-mg dose of oral doxycycline after a high-risk bite from a blacklegged tick. Currently, it is not known how Lyme disease post-exposure prophylaxis (PEP) might vary by region and healthcare system. We identified single-dose doxycycline medication orders in three healthcare systems in states with high incidence of Lyme disease and compared associated patient and provider characteristics. Electronic health record data during 2012 – 2016 were obtained from three healthcare systems: Geisinger (Pennsylvania), Marshfield Clinic (Wisconsin), and Mayo Clinic (Minnesota/Wisconsin). Creation of analytic variables and analysis were harmonized across the three sites. Medication orders for single-dose doxycycline ≤200 mg that were accompanied by specific key words or diagnostic codes (e.g., tick bite; Lyme disease prevention) were considered evidence of PEP. Manual chart review was performed from a random subset to evaluate the algorithms used to identify PEP. Among 2,937,585 patients with at least one medication order or clinical encounter during the study period, 14,102 single-dose doxycycline orders for Lyme disease PEP for 13,172 unique patients were identified. The typical patient receiving PEP was older (mean age 51 – 58 years), male (56 – 59%), and non-Hispanic White (81 – 98%). The annual seasonality of medication orders was bimodal, with peaks occurring during April – July and October – November. The most common encounter setting was an outpatient clinic or urgent care center (80 – 91%); medication orders after patient phone calls in the absence of an in-person visit occurred frequently (14 – 19%) in two health systems. Chart abstractions (n=600) revealed instances of PEP prescribed inappropriately (e.g., bite from a non-blacklegged tick; patient with symptoms of acute Lyme disease). Lyme disease PEP with a single dose of doxycycline was frequently prescribed in healthcare systems where there is a high incidence of Lyme disease. PEP was most commonly prescribed to non-Hispanic Whites over the age of 50 years. Public health initiatives for tickborne disease prevention should include clinician education on the appropriate use of Lyme disease PEP. Anna M. Schotthoefer, PhD, HelixBind (Other Financial or Material Support, salary support) John Zeuli, PharmD, INSMED (Other Financial or Material Support, honoraria for educational speaking)
- 4 December 2021
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 8 (Supplement) , S690
Open Access1198. Lyme Disease Post-Exposure Prophylaxis by Single-Dose Doxycycline in Three Healthcare Systems
Lyme disease, the most common tickborne disease in the United States, may be prevented by taking a single 200-mg dose of oral doxycycline after a high-risk bite from a blacklegged tick. Currently, it is not known how Lyme disease post-exposure prophylaxis (PEP) might vary by region and healthcare system. We identified single-dose doxycycline medication orders in three healthcare systems in states with high incidence of Lyme disease and compared associated patient and provider characteristics. Electronic health record data during 2012 – 2016 were obtained from three healthcare systems: Geisinger (Pennsylvania), Marshfield Clinic (Wisconsin), and Mayo Clinic (Minnesota/Wisconsin). Creation of analytic variables and analysis were harmonized across the three sites. Medication orders for single-dose doxycycline ≤200 mg that were accompanied by specific key words or diagnostic codes (e.g., tick bite; Lyme disease prevention) were considered evidence of PEP. Manual chart review was performed from a random subset to evaluate the algorithms used to identify PEP. Among 2,937,585 patients with at least one medication order or clinical encounter during the study period, 14,102 single-dose doxycycline orders for Lyme disease PEP for 13,172 unique patients were identified. The typical patient receiving PEP was older (mean age 51 – 58 years), male (56 – 59%), and non-Hispanic White (81 – 98%). The annual seasonality of medication orders was bimodal, with peaks occurring during April – July and October – November. The most common encounter setting was an outpatient clinic or urgent care center (80 – 91%); medication orders after patient phone calls in the absence of an in-person visit occurred frequently (14 – 19%) in two health systems. Chart abstractions (n=600) revealed instances of PEP prescribed inappropriately (e.g., bite from a non-blacklegged tick; patient with symptoms of acute Lyme disease). Lyme disease PEP with a single dose of doxycycline was frequently prescribed in healthcare systems where there is a high incidence of Lyme disease. PEP was most commonly prescribed to non-Hispanic Whites over the age of 50 years. Public health initiatives for tickborne disease prevention should include clinician education on the appropriate use of Lyme disease PEP. Anna M. Schotthoefer, PhD, HelixBind (Other Financial or Material Support, salary support) John Zeuli, PharmD, INSMED (Other Financial or Material Support, honoraria for educational speaking)
- Open Access
- 20 October 2020
- Published by Springer Nature in BMC Public Health
- Vol. 20 (1) , 1-15
Tickborne disease awareness and protective practices among U.S. Forest Service employees from the upper Midwest, USA
Background: People with occupations that require them to spend time working outdoors in suitable tick habitats are predicted to be at an increased risk for tick-borne diseases (TBDs). However, few studies have assessed the risks of outdoor employees in the United States. Methods: We conducted a cross-sectional survey to collect data on exposure to ticks and TBD infections among U.S. Forest Service employees in a high TBD incidence region of northern Wisconsin, and to examine employee knowledge, attitudes, and practices (KAPs) regarding TBDs to help guide future education and prevention programs. Chi-square contingency tables, calculations of odds ratios, and logistic regression models were used to identify associations among self-reported employee factors, the proportion of correctly answered knowledge questions, their ranked concern for TBDs, adherence to practicing preventive behaviors, and willingness to pay for protective measures. Results: Ninety-five employees completed the survey. Nearly all respondents (97%) reported recent tick exposure, with 27% reporting encountering 10 or more ticks per week during peak tick season. Employee knowledge of TBD was high (median score: 80% correct). Fifty-nine percent of respondents had high concern for TBDs, and there was high adherence to conducting body checks for ticks (83% reported always doing them), but only moderate use of tick repellents (24% reported always and 60% reported occasionally using). High concern for TBD (adjusted odds ratio (aOR) = 6.32 [95% confidence intervals, 1.97–20.28]), a history of TBD diagnosis (aOR = 5.88 [1.41–24.55]), and older age (≥ 46 years) (aOR = 3.29 [1.00–10.84]) were positively associated with high practice adherence. Respondents suggested they would be willing to pay for personal protective methods and get a hypothetical vaccine for Lyme disease, but not community-wide efforts to control ticks. Conclusions: Our study provides evidence that U.S. Forest Service employees in Wisconsin represent a high risk group for TBD, and despite relatively high TBD knowledge and engagement in tick protection activities, efforts are needed to reduce their risks for tick bites. More generally, our findings suggest that studies to better understand the factors related to the adoption and effectiveness of public health interventions are needed.
- 20 October 2020
- Published by Springer Nature in BMC Public Health
- Vol. 20 (1) , 1-15
Open AccessTickborne disease awareness and protective practices among U.S. Forest Service employees from the upper Midwest, USA
Background: People with occupations that require them to spend time working outdoors in suitable tick habitats are predicted to be at an increased risk for tick-borne diseases (TBDs). However, few studies have assessed the risks of outdoor employees in the United States. Methods: We conducted a cross-sectional survey to collect data on exposure to ticks and TBD infections among U.S. Forest Service employees in a high TBD incidence region of northern Wisconsin, and to examine employee knowledge, attitudes, and practices (KAPs) regarding TBDs to help guide future education and prevention programs. Chi-square contingency tables, calculations of odds ratios, and logistic regression models were used to identify associations among self-reported employee factors, the proportion of correctly answered knowledge questions, their ranked concern for TBDs, adherence to practicing preventive behaviors, and willingness to pay for protective measures. Results: Ninety-five employees completed the survey. Nearly all respondents (97%) reported recent tick exposure, with 27% reporting encountering 10 or more ticks per week during peak tick season. Employee knowledge of TBD was high (median score: 80% correct). Fifty-nine percent of respondents had high concern for TBDs, and there was high adherence to conducting body checks for ticks (83% reported always doing them), but only moderate use of tick repellents (24% reported always and 60% reported occasionally using). High concern for TBD (adjusted odds ratio (aOR) = 6.32 [95% confidence intervals, 1.97–20.28]), a history of TBD diagnosis (aOR = 5.88 [1.41–24.55]), and older age (≥ 46 years) (aOR = 3.29 [1.00–10.84]) were positively associated with high practice adherence. Respondents suggested they would be willing to pay for personal protective methods and get a hypothetical vaccine for Lyme disease, but not community-wide efforts to control ticks. Conclusions: Our study provides evidence that U.S. Forest Service employees in Wisconsin represent a high risk group for TBD, and despite relatively high TBD knowledge and engagement in tick protection activities, efforts are needed to reduce their risks for tick bites. More generally, our findings suggest that studies to better understand the factors related to the adoption and effectiveness of public health interventions are needed.
- Open Access
- 7 October 2020
- Published by Springer Nature in Research Square
Tickborne disease awareness and protective practices among U.S. Forest Service employees from the Upper Midwest, USA
Background: People with occupations that require them to spend time working outdoors in suitable tick habitats are predicted to be at an increased risk for tick-borne diseases (TBDs). However, few studies have assessed the risks of outdoor employees in the United States.Methods: We conducted a cross-sectional survey to collect data on exposure to ticks and TBD infections among U.S. Forest Service employees in a high TBD incidence region of northern Wisconsin, and to examine employee knowledge, attitudes, and practices (KAPs) regarding TBDs to help guide future education and prevention programs. Chi-square contingency tables, calculations of odds ratios, and logistic regression models were used to identify associations among self-reported employee factors, the proportion of correctly answered knowledge questions, their ranked concern for TBDs, adherence to practicing preventive behaviors, and willingness to pay for protective measures. Results: Ninety-five employees completed the survey. Nearly all respondents (97%) reported recent tick exposure, with 27% reporting encountering 10 or more ticks per week during peak tick season. Employee knowledge of TBD was high (median score: 80% correct). Fifty-nine percent of respondents had high concern for TBDs, and there was high adherence to conducting body checks for ticks (83% reported always doing them), but only moderate use of tick repellents (24% reported always and 60% reported occasionally using). High concern for TBD (adjusted odds ratio (aOR) = 6.32 [95% confidence intervals: 1.97 – 20.28]), a history of TBD diagnosis (aOR = 5.88 [1.41-24.55]), and older age (≥ 46 years) (aOR = 3.29 [1.00 – 10.84]) were positively associated with high practice adherence. Respondents suggested they would be willing to pay for personal protective methods and get a hypothetical vaccine for Lyme disease, but not community-wide efforts to control ticks. Conclusions: Our study provides evidence that U.S. Forest Service employees in Wisconsin represent a high risk group for TBD, and despite relatively high TBD knowledge and engagement in tick protection activities, efforts are needed to reduce their risks for tick bites. More generally, our findings suggest that studies to better understand the factors related to the adoption and effectiveness of public health interventions are needed.
- 7 October 2020
- Published by Springer Nature in Research Square
Open AccessTickborne disease awareness and protective practices among U.S. Forest Service employees from the Upper Midwest, USA
Background: People with occupations that require them to spend time working outdoors in suitable tick habitats are predicted to be at an increased risk for tick-borne diseases (TBDs). However, few studies have assessed the risks of outdoor employees in the United States.Methods: We conducted a cross-sectional survey to collect data on exposure to ticks and TBD infections among U.S. Forest Service employees in a high TBD incidence region of northern Wisconsin, and to examine employee knowledge, attitudes, and practices (KAPs) regarding TBDs to help guide future education and prevention programs. Chi-square contingency tables, calculations of odds ratios, and logistic regression models were used to identify associations among self-reported employee factors, the proportion of correctly answered knowledge questions, their ranked concern for TBDs, adherence to practicing preventive behaviors, and willingness to pay for protective measures. Results: Ninety-five employees completed the survey. Nearly all respondents (97%) reported recent tick exposure, with 27% reporting encountering 10 or more ticks per week during peak tick season. Employee knowledge of TBD was high (median score: 80% correct). Fifty-nine percent of respondents had high concern for TBDs, and there was high adherence to conducting body checks for ticks (83% reported always doing them), but only moderate use of tick repellents (24% reported always and 60% reported occasionally using). High concern for TBD (adjusted odds ratio (aOR) = 6.32 [95% confidence intervals: 1.97 – 20.28]), a history of TBD diagnosis (aOR = 5.88 [1.41-24.55]), and older age (≥ 46 years) (aOR = 3.29 [1.00 – 10.84]) were positively associated with high practice adherence. Respondents suggested they would be willing to pay for personal protective methods and get a hypothetical vaccine for Lyme disease, but not community-wide efforts to control ticks. Conclusions: Our study provides evidence that U.S. Forest Service employees in Wisconsin represent a high risk group for TBD, and despite relatively high TBD knowledge and engagement in tick protection activities, efforts are needed to reduce their risks for tick bites. More generally, our findings suggest that studies to better understand the factors related to the adoption and effectiveness of public health interventions are needed.
- Open Access
- 15 July 2020
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 17 (14) , 5105
Spatio-Temporal Dynamics of Tick-Borne Diseases in North-Central Wisconsin from 2000–2016
Lyme disease is a well-recognized public health problem in the USA, however, other tick-borne diseases also have major public health impacts. Yet, limited research has evaluated changes in the spatial and temporal patterns of non-Lyme tick-borne diseases within endemic regions. Using laboratory data from a large healthcare system in north-central Wisconsin from 2000–2016, we applied a Kulldorf’s scan statistic to analyze spatial, temporal and seasonal clusters of laboratory-positive cases of human granulocytic anaplasmosis (HGA), babesiosis, and ehrlichiosis at the county level. Older males were identified as the subpopulation at greatest risk for non-Lyme tick-borne diseases and we observed a statistically significant spatial and temporal clustering of cases (p < 0.05). HGA risk shifted from west to east over time (2000–2016) with a relative risk (RR) ranging from 3.30 to 11.85, whereas babesiosis risk shifted from south to north and west over time (2004–2016) with an RR ranging from 4.33 to 4.81. Our study highlights the occurrence of non-Lyme tick-borne diseases, and identifies at-risk subpopulations and shifting spatial and temporal heterogeneities in disease risk. Our findings can be used by healthcare providers and public health practitioners to increase public awareness and improve case detection.
- 15 July 2020
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 17 (14) , 5105
Open AccessSpatio-Temporal Dynamics of Tick-Borne Diseases in North-Central Wisconsin from 2000–2016
Lyme disease is a well-recognized public health problem in the USA, however, other tick-borne diseases also have major public health impacts. Yet, limited research has evaluated changes in the spatial and temporal patterns of non-Lyme tick-borne diseases within endemic regions. Using laboratory data from a large healthcare system in north-central Wisconsin from 2000–2016, we applied a Kulldorf’s scan statistic to analyze spatial, temporal and seasonal clusters of laboratory-positive cases of human granulocytic anaplasmosis (HGA), babesiosis, and ehrlichiosis at the county level. Older males were identified as the subpopulation at greatest risk for non-Lyme tick-borne diseases and we observed a statistically significant spatial and temporal clustering of cases (p < 0.05). HGA risk shifted from west to east over time (2000–2016) with a relative risk (RR) ranging from 3.30 to 11.85, whereas babesiosis risk shifted from south to north and west over time (2004–2016) with an RR ranging from 4.33 to 4.81. Our study highlights the occurrence of non-Lyme tick-borne diseases, and identifies at-risk subpopulations and shifting spatial and temporal heterogeneities in disease risk. Our findings can be used by healthcare providers and public health practitioners to increase public awareness and improve case detection.